Mesenchymal Stem Cells: An Overview of Their Potential in Cell-Based Therapy for Diabetic Nephropathy | Zendy

Yan Wu | Zendy; Chunlei Zhang | Zendy; Ran Guo | Zendy; Dan Wu | Zendy; Jiayi Shi | Zendy; Luxin Li | Zendy; Yanhui Chu | Zendy; Xiaohuan Yuan | Zendy; Jie Gao | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Mesenchymal Stem Cells: An Overview of Their Potential in Cell-Based Therapy for Diabetic Nephropathy

Author(s) -

Yan Wu,

Chunlei Zhang,

Ran Guo,

Dan Wu,

Jiayi Shi,

Luxin Li,

Yanhui Chu,

Xiaohuan Yuan,

Jie Gao

Publication year - 2021

Publication title -

stem cells international

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.205

H-Index - 64

eISSN - 1687-9678

pISSN - 1687-966X

DOI - 10.1155/2021/6620811

Subject(s) - mesenchymal stem cell , medicine , diabetic nephropathy , stem cell , disease , clinical trial , diabetes mellitus , bioinformatics , stem cell therapy , stromal cell , regeneration (biology) , cell therapy , intensive care medicine , cancer research , pharmacology , pathology , biology , endocrinology , microbiology and biotechnology

Diabetic nephropathy (DN) is a devastating complication associated with diabetes mellitus, and it is the leading cause of end-stage renal diseases (ESRD). Over the last few decades, numerous studies have reported the beneficial effects of stem cell administration, specifically mesenchymal stem or stromal cells (MSCs), on tissue repair and regeneration. MSC therapy has been considered a promising strategy for ameliorating the progression of DN largely based on results obtained from several preclinical studies and recent Phase I/II clinical trials. This paper will review the recent literature on MSC treatment in DN. In addition, the roles and potential mechanisms involved in MSC treatment of DN will be summarized, which may present much needed new drug targets for this disease. Moreover, the potential benefits and related risks associated with the therapeutic action of MSCs are elucidated and may help in achieving a better understanding of MSCs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research